Top Markets
Coin of the day
AegirBio AB (publ) AegirBio AB (publ)

AegirBio AB (publ)

AEGIR
株式のランク #38668
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
株価
$0.04057595
最終同期: 2024-08-05
時価総額
$863.62K
変化(1日)
0.31%
変化(1年)
0.00%
SE
取引 AegirBio AB (publ) (AEGIR)

カテゴリー

AegirBio AB (publ)(AEGIR)の収益
Sep 2024 時点の収益 TTM: $-98.54
AegirBio AB (publ) の最新の財務報告によると、現在の収益 (TTM) は $-98.54 です。2022 年には $163.61K の収益があり、これは 2021 年の $1.47M と比較して 減少 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
AegirBio AB (publ) の収益履歴(2019 ~ 2026)
各年末の収益
収益 変化
2026 (TTM) $-98.54 -101.08%
2023 $9.12K -94.43%
2022 $163.61K -88.85%
2021 $1.47M 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
同業他社の収益
企業 収益 収益の差
$11.03B -11,197,900,645.87%
US
$34.74B -35,251,257,961.59%
FR
- -
JP
$20.84B -21,147,778,817.05%
US
- -
CH